menu search

IQV / IQVIA Holdings (IQV) Q4 2022 Earnings Call Transcript

IQVIA Holdings (IQV) Q4 2022 Earnings Call Transcript
IQVIA Holdings (NYSE:IQV ) Q4 2022 Earnings Conference Call February 10, 2023 9:00 AM ET Company Participants Nick Childs - Senior Vice President, Investor Relations and Treasurer Ari Bousbib - Chairman and Chief Executive Officer Ron Bruehlman - Executive Vice President and Chief Financial Officer Eric Sherbet - Executive Vice President and General Counsel Mike Fedock - Senior Vice President, Financial Planning and Analysis Gustavo Perrone - Senior Director, Investor Relations Conference Call Participants Dan Leonard - Credit Suisse Eric Coldwell - Robert W. Baird Justin Bowers - Deutsche Bank Jack Meehan - Nephron Luke Sergott - Barclays Sandy Draper - Guggenheim Elizabeth Anderson - Evercore ISI Charles Rhyee - Cowen Operator Ladies and gentlemen, thank you for standing by. Read More
Posted: Feb 10 2023, 11:40
Author Name: Seeking Alpha
Views: 092168

IQV News  

IQVIA Holdings (IQV) Q3 Earnings Surpass Estimates

By Zacks Investment Research
November 1, 2023

IQVIA Holdings (IQV) Q3 Earnings Surpass Estimates

IQVIA Holdings (IQV) came out with quarterly earnings of $2.49 per share, beating the Zacks Consensus Estimate of $2.46 per share. This compares to ea more_horizontal

IQVIA (IQV) and argenx Partner to Advance Autoimmune Care

By Zacks Investment Research
October 5, 2023

IQVIA (IQV) and argenx Partner to Advance Autoimmune Care

IQVIA (IQV) and argenx expand collaboration to advance rare autoimmune treatments through innovative pharmacovigilance. more_horizontal

Court strikes down federal rule that sharply increased prescription costs for many patients

By Market Watch
October 2, 2023

Court strikes down federal rule that sharply increased prescription costs for many patients

A federal court on Friday struck down a rule that sharply increased out-of-pocket prescription costs for many patients with complex conditions. more_horizontal

Here's Why Investors Should Retain IQVIA (IQV) Stock Now

By Zacks Investment Research
September 8, 2023

Here's Why Investors Should Retain IQVIA (IQV) Stock Now

An addressable market size and strong healthcare-specific global IT infrastructure boost IQVIA (IQV). more_horizontal

3 Biotech Stocks That Wall Street Analysts Can't Get Enough Of

By InvestorPlace
August 30, 2023

3 Biotech Stocks That Wall Street Analysts Can't Get Enough Of

This year has not been kind to biotech stocks, as the sector's most popular ETF, the iShares Biotechnology ETF (NASDAQ: IBB ), has fallen about 3% so more_horizontal

IQVIA (IQV) Stock Improves 8% in Three Months: Here's How

By Zacks Investment Research
August 25, 2023

IQVIA (IQV) Stock Improves 8% in Three Months: Here's How

IQVIA (IQV) aims at market expansion through innovation and service improvements. more_horizontal

IQVIA Holdings' (IQV) Q2 Earnings Beat Estimates, Decline Y/Y

By Zacks Investment Research
August 1, 2023

IQVIA Holdings' (IQV) Q2 Earnings Beat Estimates, Decline Y/Y

IQVIA Holdings (IQV) second-quarter 2023 revenues improve year over year. more_horizontal

IQVIA (IQV) Reports Q2 Earnings: What Key Metrics Have to Say

By Zacks Investment Research
August 1, 2023

IQVIA (IQV) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for IQVIA (IQV) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering more_horizontal


Search within

Pages Search Results: